High Throughput Screening Identifies Novel Lead Compounds with Activity against Larval, Juvenile and Adult Schistosoma mansoni.
An estimated 600 million people are affected by the helminth disease schistosomiasis caused by parasites of the genus Schistosoma. There is currently only one drug recommended for treating schistosomiasis, praziquantel (PZQ), which is effective against adult worms but not against the juvenile stage....
Saved in:
| Main Authors: | Nuha R Mansour, Ross Paveley, J Mark F Gardner, Andrew S Bell, Tanya Parkinson, Quentin Bickle |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-04-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0004659&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The discovery of a novel series of compounds with single-dose efficacy against juvenile and adult Schistosoma species.
by: J Mark F Gardner, et al.
Published: (2021-07-01) -
Gene expression patterns in larval Schistosoma mansoni associated with infection of the mammalian host.
by: Sophia J Parker-Manuel, et al.
Published: (2011-08-01) -
Development of a spirulina feed effective only for the two larval stages of Schistosoma mansoni, not the intermediate host mollusc
by: Takashi Kumagai, et al.
Published: (2025-04-01) -
Acute encephalitis caused by Schistosoma mansoni
by: Paulo P. Christo, et al.
Published: (2010-12-01) -
Optimizing the therapeutic benefits of synriam combined with praziquantel in mice harbouring juvenile and mature Schistosoma mansoni
by: Abdel-Nasser A. Sabra, et al.
Published: (2025-08-01)